subject: Cefaclor Hospitals steady growth of 35% with a bright future - cephalosporin antibiotics, bulk drugs - the pharmaceutical industries [print this page] Cefaclor Hospitals steady growth of 35% with a bright future - cephalosporin antibiotics, bulk drugs - the pharmaceutical industries
By penicillin industrial salt had frequent high price impact Cephalosporin Crowe has also jumped on the market price high.
From the United States Scrip, Market.Letter Journal of Medicine two data show that from 1987 to 1997, cefaclor 10th consecutive year to enter the world top ten best-selling drugs, became the first best-selling Antibiotic , And in a doctor's prescription sales volume and retail pharmacy antibiotic class on the first home. According to statistics, the world's annual consumption of cefaclor in 1993 exceeded 400 tons to 450 tons in 1996; the preparation of the annual sales will remain at 10 billion to 1.1 billion U.S. dollars.
Now cefaclor patent has expired, their suppliers than Eli Lilly and Shionogi pharmaceutical companies in Japan, the addition of Italy ACSDobfar (France Roussel-Uclaf biochemical subsidiary) and India Ranbaxy and other companies. Domestic Cefaclor API Obtain approval of the manufacturer of about 11, the main production enterprises in Guangzhou Baiyun Mountain, Suzhou, China United, Zhejiang Onlly Kang; first get the approval was in 2002, Shandong Xinhua - Ken Fu Pharmaceutical Co., Ltd., since 2005 on no business re-registration.
Of smoke generic drug competition has led to cefaclor price down, but from another perspective, consider that this is also beneficial to the market expansion, estimated total sales in the future world of cefaclor still room for growth.
Risen 2450 ~ 2500 yuan / kg, the increasingly fierce market competition API
Recent years, due to the upstream cefaclor Intermediate 7-ACCA's key technology in China has still not been a breakthrough in the international market, so China is almost no advantage. Domestic use so far most of cefaclor bulk drugs from India, the Indian master cefaclor Intermediate The key production technologies. Cefaclor in the supply of domestic bulk drug imports about 78 companies are mostly of Indian products. According to statistics, in 2006, China's import volume of cefaclor 42 tons, an increase of 8%; 7-ACCA imports of 43 tons, up 45.52 percent year on year.
Since last year, the price of penicillin industrial salt has been great concern, from January 2007 to March this year, the price curve wavy change, and then makes way cefaclor price fluctuations, the current has risen to 2450 ~ 2,500 yuan / kg. The reason may be a number of vendors trying to take advantage of raw materials before the rally and the rally of penicillin industrial salt will lift up prices.
Penicillin industrial salt is now the price drop, it is estimated cefaclor lower prices will follow, together with the entry of new enterprises, the future of the market competition will become fiercer.
Hospitals bullish, the market steadily preparation
1994 2 months, cefaclor first developed in China by the Shandong Zibo Xinda pharmacy first to market, brand name new Darrow. The following years, due to strong hopes for the market prospects of cefaclor, cefaclor domestic agents quickly set off a wave of development.
2006 cefaclor preparation manufacturers to 45. The main agents of domestic production enterprises of Shandong Zibo Xinda Pharmaceutical, Harbin reputation value for medicine, Hainan clover pharmaceutical, Baiyun Mountain in Guangzhou Guanghua Pharmaceutical Company, Suzhou third pharmaceutical, pharmaceutical preparations company in Sichuan, Zhejiang Asia-Pacific Pharmaceutical , Kunmingbeike Norton pharmacy. Which granule (granules for oral suspension, dry syrup) production plant with a new up to the pharmaceutical, Zibo, Shandong, Shanghai, U.S. superior pharmaceutical, pharmaceutical industry company of Suzhou, Guangzhou Baiyun Mountain, Shantou stone Pharmaceutical Factory, etc.; release film production plant with a new up to the pharmaceutical, Zibo, Shandong, Zhejiang Onlly health pharmacy.
In the hospital market, cefaclor capsules, granules were incorporated into domestic first national basic medical insurance and industrial injury insurance agent directory, directory of 2004 Medicare amendment in turn tablets into, so as to promote the cefaclor in 2007 variety of antibiotics in the hospital drug market growth rate of 35% of the species into the antibiotic market growth top ten.
